Danjuma Q. in

Danjuma Q.

Observer · DISC type ci
Senior Director - AI & Biotech Innovation, Lilly Ventures at Eli Lilly and Company
📍 San Francisco Bay Area, United States

Danjuma is the Senior Director of AI & Biotech Innovation at Lilly Ventures, where he leverages his unique background as a Ph. D. scientist and venture investor. Transitioning from computational genomics at AbbVie, he now focuses on early-stage biotech investments. Colleagues describe him as having one of the brightest minds, with immense integrity and vision.

Fueled by a personal goal to "help those in need, " Danjuma has a history of community involvement, including serving on the board for the non-profit Degrees of Change. In college, he was a multi-sport athlete, participating in both football and track and field, and was part of a leadership and scholarship program.

Unique fact: While an undergraduate, he was instrumental in the development of the new bioinformatics degree program at Whitworth University.

Read the full overview →
Experience
12 Years
Current Role
Senior Director - AI & Biotech Innovation, Lilly Ventures
Job Level
Senior
Location
San Francisco Bay Area, United States
Personality Overview

How Danjuma shows up

Value Driven
Example Seeker
Assertive

They are generally good communicators and can be hard to convince. They can sound friendly and charming but can quickly change gears to become inquisitive and probing. They ask a lot of questions and rely heavily on information and collaterals.

Priorities

Topics Danjuma cares about

AI in Biotech
His current role at Lilly Ventures is centered on identifying and investing in companies at the intersection of artificial intelligence and biotechnology.
Biotech Investing
He has extensive experience in corporate venture capital, previously serving as an Associate Director at AbbVie Ventures and joining the boards of portfolio companies.
+5 more topics Login to view topics
Career

Work history

11-2025
Senior Director - AI & Biotech Innovation, Lilly Ventures
Eli Lilly and Company
2-2022 - 11-2025
Associate Director, AbbVie Ventures
AbbVie
2-2020 - 2-2022
Strategy Leadership Development Program
AbbVie
2-2017 - 5-2020
Senior Scientist, Computational Genomics. AbbVie Genomics Research Center
AbbVie
3-2020 - 3-2023
Co-Chair - Career Development Committee
American Society of Human Genetics
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Master's degree
Northwestern University - Kellogg School of Management
Doctor of Philosophy (Ph.D.)
UC San Diego
Social presence
in
Behavioral profile

DISC profile (public)

c

Calculativeness (C)

Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.

Other Eli Lilly and Company Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Danjuma. Free, 10 seconds.